Citation Impact
Citing Papers
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
1976 StandoutNobel
A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous System
1996 StandoutNobel
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
1994 StandoutNature
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP
1991 Standout
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
1990 Standout
Identification of a prostacyclin receptor coupled to the adenylate cyclase system via a stimulatory GTP-binding protein in mouse mastocytoma P-815 cells
1990
Facilitatory and inhibitory transmitters modulate calcium influx during action potentials in Aplysia sensory neurons
1990 StandoutNobel
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
The importance of selenium to human health
2000 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
cPLA2 is phosphorylated and activated by MAP kinase
1993 Standout
Role of endothelium in responses of vascular smooth muscle.
1983 StandoutNobel
Prostacyclin and Blood Coagulation
1981 StandoutNobel
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Control of elevated pulmonary vascular resistance in neonatal swine with prostacyclin (PGI2)
1979
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
Prooxidant States and Tumor Promotion
1985 StandoutScience
The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms.
1980
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes
1979
Estimated rate of prostacyclin secretion into the circulation of normal man.
1981
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
The leukotrienes: a new group of biologically active compounds
1981 StandoutNobel
Intracellular phospholipases A
1980
Renal actions of prostacyclin
1978 StandoutNatureNobel
Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
1985 StandoutNobel
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
1983
Biotransformation and cardiovascular effects of arachidonic acid in the dog
1979 StandoutNobel
Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids.
1976
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Prostacyclin is a circulating hormone
1978 StandoutNatureNobel
RELEASE OF MEDIATORS OF ANAPHYLAXIS: INHIBITION OF PROSTAGLANDIN SYNTHESIS AND THE MODIFICATION OF RELEASE OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS AND HISTAMINE
1978
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
1979 StandoutNobel
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation
1979 Nature
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Prostacyclin is not a circulating hormone in man
1982
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
How is the level of free arachidonic acid controlled in mammalian cells?
1982
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
1980 StandoutNatureNobel
SOME DIRECT AND REFLEX CARDIOVASCULAR ACTIONS OF PROSTACYCLIN (PGI2) AND PROSTAGLANDIN E2 IN ANAESTHETIZED DOGS
1980 StandoutNobel
PHOSPHOLIPASE A2 ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDS
1978 StandoutNobel
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
1987 StandoutScienceNobel
Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex.
1989 Standout
RECIRCULATION OF PROSTACYCLIN (PGI2) IN THE DOG
1978 StandoutNobel
Identification of the prostacyclin receptor by use of [15-3H1]19-(3-azidophenyl)-20-norisocarbacyclin, an irreversible specific photoaffinity probe.
1992 StandoutNobel
Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen
1985
Prostaglandins and Thromboxanes
1978 StandoutNobel
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
1980 Nature
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
1986 Standout
Cytoprotection by prostaglandins
1979
Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
1982 Standout
Mediators produced by the endothelial cell.
1988 Nobel
The mode of action of aspirin and similar compounds
1976 StandoutNobel
ASSOCIATION BETWEEN CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION AND SERUM SELENIUM IN A MATCHED-PAIR LONGITUDINAL STUDY
1982
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
1992
Prevention of coronary platelet aggregation with a phosphodiesterase inhibitor RX-RA 69
1985
Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the Dog
1981 StandoutNobel
Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids
1976 StandoutNatureNobel
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.
1988
Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
1979
Effects of intravenous prostacyclin in variant angina.
1982
A new approach to anti-inflammatory drugs
1979 StandoutNobel
Works of A. Ocetkiewicz being referenced
In vivo method for quantitation of anti-platelet potency of drugs
1978
Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig
1975
Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig
1975
De-aggregatory action of prostacyclin and its enhancement by theophylline
1978
Lungs as a generator of prostacyclin — Hypothesis on physiological significance
1978
Generation of prostacyclin by lungs in vivo and its release into the arterial circulation
1978 Nature